Pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency: Unique clinical symptoms and non-specific EEG characteristics

Developmental Medicine and Child Neurology

Volumn 52, Issue 7, 2010, Pages 602-603

  Gospe, Sidney M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLYCINE; INDOLEAMINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXINE; THREONINE; VANILLIC ACID;

AGITATION; ANTICONVULSANT THERAPY; BRAIN DISEASE; CATECHOLAMINE BRAIN LEVEL; CEREBROSPINAL FLUID; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; ENZYME DEFICIENCY; EPILEPSY; EYE MOVEMENT DISORDER; FACIAL EXPRESSION; GENE MUTATION; HALLUCINATION; HUMAN; INBORN ERROR OF METABOLISM; INSOMNIA; IRRITABILITY; MYOCLONUS EPILEPSY; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; PYRIDOXINE DEPENDENT EPILEPSY; PYRIDOXINE PHOSPHATE OXIDASE DEFICIENCY; SEIZURE; TREATMENT RESPONSE; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; BRAIN; BRAIN DISEASES, METABOLIC; ELECTROENCEPHALOGRAPHY; EPILEPSY; EYE MOVEMENTS; FACIAL EXPRESSION; HUMANS; INFANT; MYOCLONUS; PYRIDOXAMINEPHOSPHATE OXIDASE; PYRIDOXINE; SEIZURES; VIDEO RECORDING;

EID: 77954646191     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03668.x     Document Type: Note

References (7)

1. Basura GJ, Hagland SP, Wiltse AM, Gospe SM. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediat 2009, 168:697-704.
2. Hoffmann GF, Schmitt B, Windfuhr M. Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 2007, 30:96-9.
3. Hunt AD, Stokes J, McCrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 1954, 13:140-5.
4. Mills PB, Surtees RAH, Champion MP. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 2005, 14:1077-86.
5. Mills PB, Struys E, Jakobs C. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 2006, 12:307-9.
6. Schmitt B, Baumgartner M, Mills PB. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol http://dx.doi.org/10.1111/j.1469-8749.2010.03660.x, DOI: (Published online 29 March 2010)
7. Nabbout R, Soufflet C, Plouin P, Dulac O. Pyridoxine dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 1999, 81:F125-9.